4//SEC Filing
Suri Anish 4
Accession 0001209191-22-022578
CIK 0001645460other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:31 PM ET
Size
8.7 KB
Accession
0001209191-22-022578
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-03-31$4.88/sh−7,068$34,492→ 103,638 total - Exercise/Conversion
Restricted Stock Units
2022-03-31−16,668→ 0 total→ Common Stock (16,668 underlying) - Exercise/Conversion
Common Stock
2022-03-31+16,668→ 110,706 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]The restricted stock units vest in three equal annual installments beginning on March 31, 2020.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739130
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:31 PM ET
- Size
- 8.7 KB